Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1012 vs Gonal-f for controlled ovarian hyperstimulation in ART
CTR20181361Phase 3Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of QL1012 in female infertility, sponsored by Qilu Pharmaceutical. Started Sep 2018; status: completed.
02
Drugs
QL1012
03
Conditions
female infertility
Beyond the preview
Go deeper on CTR20181361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181361.